BARINTHUS BIOTHERAPEUTICS PLC Capital Expenditures Incurred but Not yet Paid
BARINTHUS BIOTHERAPEUTICS PLC (BRNS) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-07.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2025-05-07
- BARINTHUS BIOTHERAPEUTICS PLC capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC capital expenditures incurred but not yet paid for the quarter ending 2024-06-30 was -$95.00K.
- BARINTHUS BIOTHERAPEUTICS PLC capital expenditures incurred but not yet paid for the quarter ending 2024-03-31 was $95.00K, a 95.77% decline year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC capital expenditures incurred but not yet paid for the quarter ending 2023-06-30 was -$1.74M, a 591.81% decline year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC capital expenditures incurred but not yet paid for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- BARINTHUS BIOTHERAPEUTICS PLC capital expenditures incurred but not yet paid for fiscal 2023 was $87.00K, a 84.44% decline from fiscal 2022.
- BARINTHUS BIOTHERAPEUTICS PLC capital expenditures incurred but not yet paid for fiscal 2022 was $559.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 | |||
| 2024-12-31 | $0.00 10-K · filed 2025-03-20 | |||
| 2024-06-30 | -$95.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | ||
| 2024-03-31 | $95.00K 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $87.00K 10-K · filed 2025-03-20 | |||
| 2023-06-30 | -$1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $506.00K 10-Q · filed 2024-08-08 | $846.00K derived: sum of 3 quarters · filed 2024-08-08 | -$654.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $2.25M 10-Q · filed 2024-05-13 | $2.59M derived: sum of 2 quarters · filed 2024-05-13 | $1.09M derived: sum of 3 quarters · filed 2024-05-13 | $1.44M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $340.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$1.16M derived: sum of 2 quarters · filed 2024-03-20 | -$806.00K derived: sum of 3 quarters · filed 2024-03-20 | $559.00K 10-K · filed 2024-03-20 |
| 2022-09-30 | -$1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$1.15M derived: sum of 2 quarters · filed 2023-11-09 | $219.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $354.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.72M 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $1.36M 10-Q · filed 2023-05-12 | |||
| 2021-06-30 | -$57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $10.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $67.00K 10-Q · filed 2022-05-11 | |||
| 2020-06-30 | $1.50M 10-Q · filed 2021-08-12 |